PSMA5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.525400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.655600E-01
Normal-vs-Stage2
4.828200E-01
Normal-vs-Stage3
9.005200E-01
Normal-vs-Stage4
3.351200E-01
Stage1-vs-Stage2
5.060800E-01
Stage1-vs-Stage3
7.816600E-01
Stage1-vs-Stage4
4.952200E-01
Stage2-vs-Stage3
3.218200E-01
Stage2-vs-Stage4
6.281000E-01
Stage3-vs-Stage4
3.873000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.907400E-01
Normal-vs-AfricanAmerican
6.028200E-01
Normal-vs-Asian
2.776200E-01
Caucasian-vs-AfricanAmerican
8.837600E-01
Caucasian-vs-Asian
2.028000E-01
AfricanAmerican-vs-Asian
3.596800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.140400E-01
Normal-vs-Female
4.892000E-01
Male-vs-Female
5.966600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.948400E-01
Normal-vs-Age(41-60Yrs)
3.234000E-01
Normal-vs-Age(61-80Yrs)
6.879600E-01
Normal-vs-Age(81-100Yrs)
3.865800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.468200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.526800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.899800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.094400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.594800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.656200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.585600E-01
Normal-vs-Daily Drinker
5.394800E-01
Normal-vs-Weekly Drinker
9.306800E-01
Normal-vs-Occasional Drinker
2.379400E-01
Normal-vs-Social Drinker
3.778200E-01
Non Drinker-vs-Daily Drinker
4.848800E-01
Non Drinker-vs-Weekly Drinker
4.683000E-01
Non Drinker-vs-Occasional Drinker
1.794590E-01
Non Drinker-vs-Social Drinker
6.815400E-01
Daily Drinker-vs-Weekly Drinker
2.019200E-01
Daily Drinker-vs-Occasional Drinker
5.631400E-01
Daily Drinker-vs-Social Drinker
6.763600E-01
Weekly Drinker-vs-Occasional Drinker
3.944000E-02
Weekly Drinker-vs-Social Drinker
2.069400E-01
Occasional Drinker-vs-Social Drinker
2.344600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.898400E-01
Normal-vs-Grade 2
8.839600E-01
Normal-vs-Grade 3
8.912200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.384400E-04
Grade 1-vs-Grade 3
1.655280E-03
Grade 1-vs-Grade 4
8.898400E-01
Grade 2-vs-Grade 3
8.860800E-01
Grade 2-vs-Grade 4
8.839600E-01
Grade 3-vs-Grade 4
8.912200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.943800E-01
Normal-vs-NonDiabetic
5.389400E-01
Diabetic-vs-NonDiabetic
4.886800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.143230E-01
Normal-vs-NoPancreatitis
6.487200E-01
Pancreatitis-vs-NoPancreatitis
1.483810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.280800E-01
Normal-vs-N1
5.122800E-01
N0-vs-N1
9.674200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.586200E-04
Normal-vs-TP53-NonMutant
8.364400E-01
TP53-Mutant-vs-TP53-NonMutant
1.65640001714706E-09
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
